Valuation: Shivalik Rasayan Limited

Market Cap 349.26Cr 3.68Cr 3.22Cr 2.97Cr 2.75Cr 5.22Cr 5.31Cr 36Cr 14Cr 172.37Cr 14Cr 14Cr 595.78Cr P/E 2024
69.1x
P/E 2025 59.1x
Enterprise Value 426.02Cr 4.49Cr 3.93Cr 3.62Cr 3.36Cr 6.37Cr 6.47Cr 43Cr 17Cr 210.25Cr 17Cr 16Cr 726.72Cr EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
40.79%
Yield 2024
0.09%
Yield 2025 0.08%
27/05 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
27/05 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
27/05 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
27/05 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
13/02 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/25/29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/25/12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
30/25/30 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
24/25/24 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
26/25/26 Medicamen Biotech Limited announced that it expects to receive INR 775.7875 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD CI
04/24/04 Shivalik Rasayan Gets US FDA Nod for Pharmaceutical Ingredient Facility in Gujarat; Shares Rise 3% MT
1 day-5.00%
1 week-1.46%
Current month-6.14%
1 month-4.76%
3 months-7.70%
6 months-36.57%
Current year-37.53%
1 week 222.3
Extreme 222.3
245
1 month 206
Extreme 206
245
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
652.75
3 years 206
Extreme 206
890.05
5 years 206
Extreme 206
1,196.8
10 years 34.2
Extreme 34.2
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 17/11/2018
Director of Finance/CFO - 01/11/2001
Chief Tech/Sci/R&D Officer - 11/01/2024
Director TitleAgeSince
Director/Board Member 64 17/11/2018
Chairman 61 23/02/2002
Director/Board Member 67 18/07/2003
Date Insider Type Main position Quantity % Market Cap.
01/24/01Don 21,500 0.1382%
26/24/26Sell 1,08,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-1.46%-58.56%-71.45% 3.86Cr
+0.42%+2.43%+13.28%+51.40% 5.78TCr
+0.11%-.--%-.--%-.--% 1.3TCr
+2.55%+3.81%+53.88%+201.03% 1.11TCr
-4.72%-9.70%+30.06%+68.97% 812.7Cr
-1.98%-0.60%-30.77%-13.46% 651.79Cr
-1.60%-0.64%-8.14%+81.49% 595.63Cr
-1.37%+5.61%-11.81%-10.80% 538.82Cr
+0.88%-0.12%+19.97%+26.42% 465.52Cr
-0.97%+3.52%-37.09%-31.20% 425.79Cr
Average -1.17%+2.15%-2.92%+30.24% 1.17TCr
Weighted average by Cap. -0.12%+2.21%+10.52%+52.10%

Financials

2024 2025
Net sales 271.54Cr 2.86Cr 2.5Cr 2.31Cr 2.14Cr 4.06Cr 4.13Cr 28Cr 11Cr 134.01Cr 11Cr 11Cr 463.21Cr 309.55Cr 3.26Cr 2.85Cr 2.63Cr 2.44Cr 4.63Cr 4.7Cr 32Cr 12Cr 152.77Cr 12Cr 12Cr 528.04Cr
Net income 13Cr 13.4L 11.73L 10.81L 10.02L 19.01L 19.32L 1.3Cr 50.39L 6.28Cr 50.31L 49.22L 22Cr 17Cr 17.59L 15.39L 14.19L 13.15L 24.96L 25.37L 1.7Cr 66.16L 8.24Cr 66.05L 64.62L 28Cr
Net Debt 48Cr 50.82L 44.47L 40.98L 37.99L 72.11L 73.27L 4.91Cr 1.91Cr 24Cr 1.91Cr 1.87Cr 82Cr 77Cr 80.87L 70.77L 65.22L 60.46L 1.15Cr 1.17Cr 7.82Cr 3.04Cr 38Cr 3.04Cr 2.97Cr 130.93Cr
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
07/26/07 ₹222.30 -5.00% 1,533
06/26/06 ₹234.00 +1.96% 1,799
03/26/03 ₹229.50 -2.82% 946
02/26/02 ₹236.15 +1.72% 1,791
01/26/01 ₹232.15 -1.98% 2,707
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock